Annals of Oncology Advance Access published online on March 24, 2005
Annals of Oncology, doi:10.1093/annonc/mdi151
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Registre Bourguignon des Cancers Digestifs (INSERM EPI 0106 and CIC-EC01), Faculté de Médecine, Dijon Cedex, France
* To whom correspondence should be addressed. Background: Little is known about the management of recurrences from colorectal cancer at a population level. Materials and methods: Data was obtained from the population-based cancer registry of Côte d'Or (Burgundy, France) over a 28-year period. Univariate and multivariate analyses were performed to analyse trends in treatment and survival for local recurrence and distant metastases. Results: The proportion of patients resected for cure increased from 6.7% (1976-1984) to 23.7% (1994-2003; P <0.001) for distant metastases and from 15.9% to 58.1% (P <0.001) for local recurrence. Age and period of diagnosis were independent factors associated with a resection for cure. Rectal cancer local recurrence was less often resected for cure than colon cancer local recurrence (P=0.05). Long-term survival was observed only after resection for cure: 5-year relative survival rates were 36.1% for local recurrence and 24.0% for distant metastases. In the multivariate analysis, survival decreased with age and increased over time but significantly only over the last study period. Surgical resection and palliative chemotherapy were other determinants of prognosis for distant metastases whereas surgical resection and palliative radiotherapy did influence the prognosis for local recurrence. Conclusion: Substantial advances in the management of recurrences have been achieved over time. More effective treatments and mass screening represent promising approaches to decrease this problem.
Received September 1, 2004
Revised December 13, 2004
Accepted December 20, 2004
Original article
Time trends in the treatment and survival of recurrences from colorectal cancer
A. M. Bouvier, E-mail: Anne-Marie.Bouvier{at}u-bourgogne.fr
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Papamichael, R. Audisio, J.-C. Horiot, B. Glimelius, J. Sastre, E. Mitry, E. Van Cutsem, M. Gosney, C.-H. Kohne, and M. Aapro Treatment of the elderly colorectal cancer patient: SIOG expert recommendations Ann. Onc., January 1, 2009; 20(1): 5 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Desch, A. B. Benson III, M. R. Somerfield, P. J. Flynn, C. Krause, C. L. Loprinzi, B. D. Minsky, D. G. Pfister, K. S. Virgo, N. J. Petrelli, et al. Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline J. Clin. Oncol., November 20, 2005; 23(33): 8512 - 8519. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Krajewska, H. Kim, C. Kim, H. Kang, K. Welsh, S.-i. Matsuzawa, M. Tsukamoto, R. G. Thomas, N. Assa-Munt, Z. Piao, et al. Analysis of Apoptosis Protein Expression in Early-Stage Colorectal Cancer Suggests Opportunities for New Prognostic Biomarkers Clin. Cancer Res., August 1, 2005; 11(15): 5451 - 5461. [Abstract] [Full Text] [PDF] |
||||


